Vik Bajaj’s startup incubator at Foresite uncloaks an immunology player with a lead TYK2 inhibitor in tow

Looking at a healthcare system made more unequal by Covid-19, Foresite Capital managing director Vik Bajaj recently launched an expansive plan to launch five innovative startups to address unmet need. Just weeks after the first of those biotechs emerged from stealth, a second has now uncloaked, and it’s got immunology...

Click to view original post